Equillium (EQ) Amortizatization of Intangibles (2019 - 2025)
Equillium (EQ) reported Amortizatization of Intangibles of $14000.0 for Q1 2025, down 94.96% year-over-year from $278000.0 in Q1 2024, and down 79.71% quarter-over-quarter from $69000.0 in Q4 2024.
Equillium (EQ) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Equillium (EQ) has 7 years of Amortizatization of Intangibles data on file, last reported at $14000.0 in Q1 2025.
- Amortizatization of Intangibles for Q1 2025 came in at $14000.0, down 94.96% year-over-year; the trailing twelve-month figure through Dec 2025 was $14000.0 (down 98.14% YoY), and the FY2025 annual result was $14000.0, down 98.14% from the prior year.
- Amortizatization of Intangibles fell to $14000.0 in Q1 2025 per EQ's latest filing, from $69000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $301000.0 in Q2 2023 and troughed at -$105000.0 in Q2 2021.
- A 5-year average of $73000.0 and a median of $14000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2023: Amortizatization of Intangibles sank 1528.57% in 2021, then surged 1257.69% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$35000.0 in 2021, then soared by 31.43% to -$24000.0 in 2022, then surged by 787.5% to $165000.0 in 2023, then tumbled by 58.18% to $69000.0 in 2024, then slumped by 79.71% to $14000.0 in 2025.
- Business Quant data shows EQ's Amortizatization of Intangibles at $14000.0 in Q1 2025, $69000.0 in Q4 2024, and $166000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Mar 31, 2024 | 278,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Sep 30, 2023 | 152,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Mar 31, 2023 | 296,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Dec 31, 2022 | -24,000.00 |